System Alignment for VaccinE Delivery (SAVED): Improving Rates of Influenza and Pneumococcal Vaccination Through Patient Outreach, Improved Medical Record Accuracy and Targeted Physician Alerts

Summary

The goal of this research study is to improve rates of appropriate influenza and pneumococcal vaccination among adults who receive care at a large multi-specialty group practice in central Massachusetts.

The investigators plan to conduct a non-blinded randomized controlled trial during flu season 2014-2015 (Cycle 1). A total of 20,000 e-portal users and 10,000 non e-portal users who are identified in the Reliant Medical Group (RMG) Electronic Health Record (EHR) as not being up to date on their influenza vaccines will be randomized.

E-portal users will be randomized to receive:

* Arm 1: E-portal message with Interactive Voice Recognition (IVR) call
* Arm 2: E-portal message with no IVR call
* Arm 3: No e-portal message with IVR call OR
* Arm 4: No e-portal message with no IVR call (Control, e-portal users)

Non e-portal users will be randomized to receive either:

* Arm 5: IVR call OR
* Arm 6: no IVR call (Control, non e-portal users)

Conditions

• Influenza
• Infections, Pneumococcal

Interventions

OTHER

Arm 1: E-portal message with IVR call

Active electronic patient portal users will be randomized to receive an e-portal message and IVR calls. Both methods of outreach will provide patients with educational information about influenza vaccination, notify patients of local flu clinic schedules and elicit patient response to vaccination status and barriers.

OTHER

Arm 2: E-portal message with no IVR call

Active electronic patient portal users will be randomized to receive only an e-portal message. The e-portal message will provide patients with educational information about influenza vaccination, notification of local flu clinic schedules and elicit patient response to vaccination status and barriers.

OTHER

Arm 3: No e-portal message with IVR call

Active electronic patient portal users will be randomized to receive an IVR call. The IVR call will provide patients with educational information about influenza vaccination, notification of local flu clinic schedules and elicit patient response to vaccination status and barriers.

OTHER

Arm 5: IVR call

Non electronic patient portal users will be randomized to receive an IVR call with educational information about influenza vaccines, notification of local flu clinic schedules and elicit patient response to vaccination status and barriers.

Sponsors & Collaborators

• Reliant Medical Group

  collaborator OTHER

• Pfizer

  collaborator INDUSTRY

• University of Massachusetts, Worcester

  lead OTHER

Principal Investigators

• Sarah L Cutrona, MD, MPH · University of Massachusetts, Worcester

Study Design

Allocation

RANDOMIZED

Purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Model

FACTORIAL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2014-11-30

Primary Completion

2016-06-30

Completion

2016-12-31

Countries

• United States

Study Locations